-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Actavia Life Sciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
- Actavia Life Sciences, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$71.4K, a 98.2% increase year-over-year.
- Actavia Life Sciences, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$345K, a 91.9% increase year-over-year.
- Actavia Life Sciences, Inc. annual Operating Income (Loss) for 2023 was -$4.24M, a 3104% decline from 2022.
- Actavia Life Sciences, Inc. annual Operating Income (Loss) for 2022 was $141K.
- Actavia Life Sciences, Inc. annual Operating Income (Loss) for 2021 was -$248K, a 95.4% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)